Elicio Therapeutics (ELTX) Misses Q3 EPS by 60c

Elicio Therapeutics (NASDAQ: ELTX) reported Q3 EPS of ($0.60).

For earnings history and earnings-related data on Elicio Therapeutics (ELTX) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 4.6 calls to 1 put with a focus on with a focus on September 4 weekly 24.50 calls as share price up 2.7%
• DA Davidson Reiterates Buy Rating on CrowdStrike (CRWD) Ahead of User Conference
• Telestream Brings AI-Boosted Resolution Upscaling Powered by NVIDIA to Vantage